Bangladesh signed a deal with the Serum Institute of India on Thursday to buy 30 million doses of a potential coronavirus vaccine being developed by British drugmaker AstraZeneca.
Saidul Karim spends his days moving from shelter to shelter along the muddy paths that crisscross Kutupalong refugee settlement in Bangladesh. The families who open their doors to him know him well.
DHAKA, March 19 (Thomson Reuters Foundation) - Factory workers in Bangladesh could go hungry as global fashion brands have cancelled or delayed orders worth $138 million due to coronavirus, ...
Inquiry, Vol. 58 (January-December 2021), pp. 1-10 (10 pages) Festivals traditionally result in mass public mobility from large cities to rural or semi-urban areas in low- and middle-Income Countries ...
Cricket West Indies (CWI) said test captain Jason Holder and limited-overs skipper Kieron Pollard are among 10 players who have chosen not to travel to Bangladesh for their upcoming tour due to ...
Bangladesh showed initial success in the mass inoculation drive. However, the program was going through an alarming situation when the serum institute of India halted the shipments. Now the authority ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback